Invention Grant
- Patent Title: Compound WS 727713
- Patent Title (中): 化合物WS 727713
-
Application No.: US13354308Application Date: 2012-01-19
-
Publication No.: US08592378B2Publication Date: 2013-11-26
- Inventor: Takanao Otsuka , Hirotsugu Ueda , Keiko Fujie , Hideyuki Muramatsu , Michizane Hashimoto , Shigehiro Takase
- Applicant: Takanao Otsuka , Hirotsugu Ueda , Keiko Fujie , Hideyuki Muramatsu , Michizane Hashimoto , Shigehiro Takase
- Applicant Address: US NJ Bridgewater
- Assignee: Telsar Pharma Inc.
- Current Assignee: Telsar Pharma Inc.
- Current Assignee Address: US NJ Bridgewater
- Agency: Foley & Lardner LLP
- Priority: AU2004901919 20040408
- Main IPC: A61K38/12
- IPC: A61K38/12
Abstract:
The present invention relates to a new compound useful as a modulator of melanocortin receptors. In particular, the present invention relates to a compound WS727713, a process for production of the compound by culturing, in a culture medium, a WS727713-producing strain belonging to Pseudonocardia and recovering the compound from a culture broth, a pharmaceutical composition containing the compound, and uses of the compound.
Public/Granted literature
- US20120214731A1 COMPOUND WS 727713 Public/Granted day:2012-08-23
Information query
IPC分类:
